Enanta's Zelicapavir Shows Positive Phase 2b Results for RSV in High-Risk Adults
Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) is one of the best hot stocks to invest in.
Enanta Pharmaceuticals Inc (ENTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 2,871,862 | $36,271,617 | +4% | 0.21% |
| 2. | Deep Track Capital David Kroin | 1,956,867 | $24,715,230 | 0.4% | |
| 3. | Spruce Street Capital Alex Rosen And Simon Basseyn | 932,598 | $11,778,713 | +140% | 2.83% |
| 4. | Millennium Management Israel Englander | 882,097 | $11,140,885 | +32% | 0% |
| 5. | Renaissance Technologies Jim Simons | 665,258 | $8,402,209 | +4% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.69 | 45,000 | $256,050.00 | 846,638 | 2025-02-12 | Filing | |
| $24.45 | 500 | $12,222.50 | 1,900 | 2016-05-11 | Filing | |
| $27.04 | 2,000 | $54,080.00 | 15,295 | 2016-02-12 | Filing | |
| $34.20 | 600 | $20,520.00 | 2,000 | 2015-02-19 | Filing | |
| $33.69 | 400 | $13,476.00 | 1,400 | 2015-02-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.23 | 323 | $4,596.29 | 8,377 | 2025-12-05 | Filing | |
| $14.23 | 542 | $7,712.66 | 16,348 | 2025-12-05 | Filing | |
| $14.23 | 798 | $11,355.54 | 21,792 | 2025-12-05 | Filing | |
| $14.23 | 1,394 | $19,836.62 | 38,329 | 2025-12-05 | Filing | |
| $14.23 | 2,106 | $29,968.38 | 30,620 | 2025-12-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 84,231 | $1,227,255 | 0% | |
| 2. | 76,756 | $1,119,105 | 0% | |
| 3. | 70,764 | $1,031,739 | 0.05% | |
| 4. | 34,789 | $507,224 | 0% | |
| 5. | 29,508 | $430,227 | 0% |
News See All
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
11 Best Breakout Stocks to Buy According to Analysts
Stock markets have been on edge in response to the US President's aggressive trade war that has resulted in trade tariffs aimed at settling the trade deficit.
7 Best Nano Cap Stocks To Invest In
In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many analysts are expecting small caps to perform well in a slowing economy.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Enanta Pharmaceuticals' Fiscal Second Quarter Financial Results Conference Call. At this time, all participants are on a listen-only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Enanta Pharmaceuticals' Fiscal First Quarter Financial Results Conference Call. At this time, all participants are on a listen-only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Year-End Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Top 5 Stock Picks of Farallon Capital
In this article, we discuss the top 5 stock picks of Farallon Capital.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode.